SECTION 16 – ALCOHOL/DRUG TESTING
1. Random Testing
a. All pilots will be subject to random drug and/or alcohol testing to the extent required by applicable federal regulations.
b. The Company may conduct random drug and/or alcohol testing of pilots any time just before, during, or just after a trip sequence. A pilot undergoing drug and/or alcohol testing will, for the purpose of Federal Aviation Regulations relating to duty time and minimum rest, be deemed to be on duty until the testing collection process is completed.
c. Following positive verification of identification using photographic identification, pilots selected for random drug and/or alcohol testing will be given a written notice, in duplicate, stating the location where the pilot is to report for the collection process, and advising him that refusal or failure to immediately report and to provide the required urine and/or breath specimen will result in termination of the pilot�s employment.
2. Post Accident Testing
a. Post accident drug and/or alcohol testing of pilots will be required when the Executive Vice-President, Operations, the Vice-President, Flight Operations, or the Staff Vice-President, Safety and Regulatory Compliance determines that an event has occurred which constitutes an aircraft “accident” as defined in applicable federal regulations and the pilot�s performance contributed to the accident and/or his performance can not be completely discounted as a contributing factor to the accident.
b. Pilots required to submit to post accident testing shall do so as soon as possible after the accident. If unusual circumstances result in a delay of the testing, the pilot(s) must remain available for alcohol testing for a period of eight hours following the accident. Drug testing may be required up to thirty-two (32) hours following the accident. (Normally both drug and alcohol test collection will be required, and will be administered at the same time.)
c. If the pilot has incurred significant physical injury in the accident, medical treatment will take priority over drug and/or alcohol testing. Drug and/or alcohol testing shall be accomplished as soon as possible after necessary medial aid has been rendered.
3. Reasonable Cause Drug Testing
When reasonable cause exists, based on observable and objective criteria, to believe that a pilot is using drugs prohibited by applicable federal regulations, the Executive Vice-President, Operations, the Vice-President, Flight Operations, or the Staff Vice-President, Safety and Regulatory Compliance may require that the pilot submit to drug testing. Reasonable cause must be established by direct observation of two (2) management officials, one of whom may be a management designee, and one of whom must be trained in detecting the indications of drug use. The two officials must substantiate and concur in the decision to recommend that the pilot be tested. Once the determination is made, the testing will be done promptly. Reports and observations must be documented.
4. Reasonable Cause Alcohol Testing
When reasonable cause exists, based on articulable observation of the pilot�s appearance, behavior, speech, or body odors, to believe that a pilot is using alcohol in a way which is prohibited by applicable federal regulations, the Executive Vice-President, Operations, the Vice-President, Flight Operations, or the Staff Vice-President, Safety and Regulatory Compliance may require that the pilot submit to alcohol testing. Reasonable cause, based on such articulable observation must be established by direct observation by a management employee who is trained in detecting the indications of alcohol abuse. Once the determination is made, the testing will be done promptly. The reason for any delay shall be documented.
1. Specimen Collection
a. The Company may elect to have collections services performed by a third party agency.
b. Collection and shipment of urine specimens for drug testing shall be in accordance with applicable federal regulations.
c. Urine specimens shall be split.
d. If testing of the first half of the specimen yields a confirmed negative result, the Company shall order that the second half of the specimen be destroyed.
2. Drug Testing Laboratories
Drug testing will be performed only at laboratories certified by the National Institute of Drug Abuse.
3. Medical Review Officers
a. The Company shall designate the medical review officer (MRO). The MRO will be a licensed medical doctor who has knowledge of substance abuse.
b. The MRO shall perform his responsibilities in accordance with applicable federal regulations.
4. Retesting
a. A pilot who has been notified that his test resulted in a confirmed verified positive finding may request a retest of the split portion of the specimen by the same laboratory which tested the original sample, provided he does so within seventy-two (72) hours following such notification. At the pilot�s option and expense, the second test will be done at a different NIDA certified laboratory.
b. If a second specimen (which must also be split) was provided at the time of the original collection, the pilot may request that the second sample also be tested. At the pilot�s option and expense, the second sample will be tested at a different NIDA certified laboratory.
c. To the extent that it is practically feasible and does not conflict with applicable federal regulations, a pilot who has been notified of a confirmed verified positive result may elect to have the specimen(s) DNA tested at the pilot�s expense. DNA testing will only be done at accredited forensic laboratories which have been certified through the American Association of Blood Banks, the American Society of Crime Laboratory Directors or a laboratory that follows the technical working group for DNA analysis methods. All specimen transfer shall be done in accordance with applicable federal regulations.
d. Should the test of either the split portion of the initial specimen or the second specimen be negative, then the test shall be considered to be negative. Similarly, should the DNA testing establish conclusively that either specimen is not that of the pilot, the test shall be deemed to be negative.
5. Positive Drug Tests
a. After receiving a confirmed positive, but before verifying that result, the MRO will make all reasonable attempts to contact the pilot (including, if necessary requesting that the Vice-President, Flight Operations direct the pilot to contact the MRO) to discuss the test result.
b. Following the discussion with the pilot and any other appropriate inquiry the MRO will determine whether to verify the test result.
c. In the event that the MRO verifies the confirmed positive result, he shall in addition to any other duties, refer the matter to Continental�s Employee Assistance Program Director, who shall notify the Vice-President, Flight Operations.
Testing for alcohol shall be conducted in accordance with applicable federal regulations by appropriately certified personnel. The Company shall not be obligated to preserve breath specimens for retesting. A pilot who has been informed that he has tested positive for alcohol at a concentration of 0.02 or higher may request that a blood alcohol test be administered. Such testing must be administered as soon after the breath test as is reasonably possible.
D. Consequences of a Verified Confirmed Positive Drug Test
1. Inadvertent Ingestion
a. Inadvertent and unknowing ingestion of any drug of abuse (or its metabolite) shall not be grounds for discipline.
b. The burden of proving inadvertent and/or unknowing ingestion rests upon the pilot.
2. Illicit Drugs
a. Except as described in paragraph D.1 above, on his first such occasion, a pilot who has a verified confirmed positive drug test, shall be given the following options:
i. Voluntary resignation without eligibility for rehire.
ii. Termination for cause. However, a pilot exercising this option may be conditionally reinstated subject to the following terms and conditions:
(1) The pilot must submit to initial evaluation by Continental�s EAP Director or the Director�s designee. (Eligibility for conditional reinstatement will not be contingent upon a diagnosis of chemical dependency.)
(2) If one is recommended, the pilot must successfully complete the course of rehabilitation recommended by Continental�s EAP, including all continuing terms and conditions attached to such course of rehabilitation. The rehabilitation will be directed and facilitated by Continental�s EAP, but will be funded entirely by the pilot, except that he shall not be precluded from using any insurance benefits to which he is otherwise entitled.
(3) The pilot must execute and deliver to the EAP Director an undated letter of resignation to be used to terminate the pilot�s employment should he fail to satisfy any of the terms of this Paragraph 2 or of the rehabilitation directed by EAP.
(4) During the remainder of his career with Continental, should the pilot subsequently fail any drug test the undated letter of resignation will be accepted by the Company, and his employment severed.
(5) The pilot shall commit in writing to remain drug free for the remainder of his career at Continental and shall agree in writing to be subject to “no notice” drug testing at the direction of the Company as frequently as the Company may decide for a period of five (5) years from the completion of the formal rehabilitation program. (Following the five (5) year period during which the pilot shall be subject to no notice testing, he shall be obligated only to submit to such further testing as may be required by applicable federal regulations or this Agreement.)
(6) If the pilot fails to comply with the provisions of the conditional reinstatement, termination will result, and his right to challenge such termination through the grievance process shall be waived. No grievance of the matter shall be permitted.
(7) A pilot who is offered conditional reinstatement shall be solely responsible for ensuring that he is fully licensed and certified to perform the duties of a commercial pilot.
(8) If a pilot elects to use this option ii, but the Company nevertheless declines to conditionally reinstate him despite his compliance with the terms of this Paragraph, the Company shall reimburse him for all out of pocket costs for his course of rehabilitation.
E. Consequences of A Positive Alcohol Test
1. When a pilot�s breath alcohol test indicates an alcohol concentration between 0.02 and 0.039, he shall be retested no sooner than fifteen (15) minutes from the administration of the initial test. If the second test also indicates an alcohol concentration between 0.02 and 0.039, the pilot shall not be permitted to resume flight duties until either eight hours have elapsed since the original test, or his breath alcohol test indicates an alcohol concentration of less than 0.02. If the second test indicates an alcohol concentration below 0.02, the test shall be considered negative, and the pilot shall be permitted to resume flight duties.
2. A pilot whose breath alcohol test indicates an alcohol concentration between 0.02 and 0.039 twice within eighteen (18) months shall thereafter be subject to no notice alcohol testing for a period of twelve (12) months from the time of the second such test.
3. If a pilot�s breath alcohol test indicates an alcohol concentration of 0.04 or greater, he shall be required, as a condition of continuing employment, to undergo evaluation by Continental�s EAP Director, or the Director�s designee and to complete any rehabilitation recommended by EAP prior to resuming any flight duties. Such rehabilitation shall be funded entirely by the pilot, except that he shall not be precluded from using any insurance benefits to which he is otherwise entitled. In addition, he shall be subject to no notice alcohol testing for a period of five (5) years from the date of his completion of the formal rehabilitation program. Thereafter the pilot will not be subject to further no notice testing relating to the rehabilitation.
4. If at any time during the balance of the pilot�s career he has a breath alcohol test indicating an alcohol concentration of 0.04 or greater, he shall be forever barred from working as a pilot for Continental, or from performing any other safety sensitive duties at Continental.
1. No notice is drug and/or alcohol testing administered by the Company in aid of rehabilitation as described elsewhere in this Section. Pilots will be subject to no notice testing under each of the following circumstances.
a. The pilot has submitted to a rehabilitation program requiring no notice testing.
b. A System Board of Adjustment has directed no notice testing.
c. The pilot has had a previous verified confirmed positive drug test result, a breath alcohol test indicating an alcohol concentration of 0.04 or greater, or two breath alcohol tests indicating an alcohol concentration between 0.02 and 0.039 within eighteen (18) months.
2. During the period a pilot is subject to no notice testing, the Company may require no notice drug and/or alcohol testing as frequently as it deems necessary or advisable.
3. No notice testing may be conducted just before, during, or just after any trip sequence.
A pilot who has not had a verified confirmed positive drug test result or a breath alcohol test indicating an alcohol concentration of 0.04 or greater, may enter voluntarily into any FAA approved drug and/or alcohol rehabilitation program, including any such program recommended by Continental�s EAP. A pilot who has voluntarily entered into a rehabilitation program pursuant to this Part shall be entitled to use any accumulated sick leave to the extent needed to complete the rehabilitation program. Upon completion of the formal rehabilitation program and appropriate certification by the FAA, the pilot shall assume the bid position to which he is otherwise entitled by the terms of this Agreement.
H. Refusal or Failure to Cooperate
A pilot who refuses or fails to cooperate in any drug or alcohol test as mandated by applicable federal regulations or by this Agreement, or in any rehabilitation related testing by refusing to provide a breath or urine specimen, or a breath or urine specimen of sufficient quantity will be withheld from service without pay pending investigation. If the investigation fails to find a valid medical reason for the pilot�s failure to cooperate, or in the case of an insufficient specimen if a medical evaluation determines that there was no genuine inability to provide the required specimen, he shall be terminated.
I. General
1. Consistent with applicable federal regulations and Paragraph A.1.c, above, a pilot will be permitted to notify the Association regarding any matter concerning this Section as soon as possible.
2. A pilot who is subjected to random drug and/or alcohol testing shall receive an additional thirty (30) minutes of pay for each such occasion. (Note: alcohol and drug testing are sometimes conducted together. A pilot who is required to provide both a breath and a urine specimen on the same occasion shall receive only one payment of thirty (30) minutes for such an occurrence, not two.)
3. Except for no notice testing, drug testing shall be limited to those drugs (and their metabolites) listed in applicable federal regulations.
4. In the event that the pilot requests, or applicable federal regulations require, that a blood test be accomplished, the drawing of the blood shall only be done by a trained, qualified, medical professional, and only in a clinical setting.
5. Nothing in this Section shall be construed to require the Company to utilize or compensate a pilot who is not fully licensed and certified to perform revenue flying for the Company.
6. It is the parties intent that this Section be and remain in full compliance with all applicable federal laws and regulations. In the event that any portion of this Section is found not to be in compliance with such laws and regulations, or if later amendments to existing laws and regulations or new laws and regulations are adopted which are not consistent with the provisions of this Section, the parties will meet and confer regarding changes necessary to bring the Section into compliance.